NCT06345235View on ClinicalTrials.gov

New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 11, 2023

Primary Completion Date

July 11, 2024

Study Completion Date

July 11, 2024

Conditions
Transthyretin Amyloidosis
Interventions
DIAGNOSTIC_TEST

blood test

Assessment of the association of new biomarkers (GDF15, ST2, galectin-3, TIMP-1, MMP-9, NfL) and plasma prothrombotic potential in groups 1, 2, 3

Trial Locations (1)

31-202

RECRUITING

John Paul II Hospital, Krakow

All Listed Sponsors
lead

John Paul II Hospital, Krakow

OTHER